Paronychia Treatment Guidelines

Introduction to Paronychia Treatment

• The European Society for Medical Oncology (ESMO) guidelines recommend combination topical therapy with antibiotics and corticosteroids for paronychia, with topical povidone iodine 2% being the most evidence-based first-line antiseptic agent 1, 2

Treatment Approach by Severity

• For grade 1 paronychia, apply topical povidone iodine 2% twice daily as the primary antiseptic agent, and combine with topical antibiotics and mid-to-high potency topical corticosteroid ointment applied to nail folds twice daily 1, 2, 3, 4, 5
• For grade 2 paronychia, continue topical povidone iodine 2% twice daily, and add combination topical antibiotics with corticosteroids 1, 2, 4, 5, 6
• Consider oral antibiotics if infection is suspected in grade 2 paronychia, but obtain bacterial/viral/fungal cultures first 1, 2

Adjunctive Measures

• Daily dilute vinegar soaks (50:50 dilution) to nail folds for 10-15 minutes twice daily can be used as an adjunctive measure 4, 5
• Apply antiseptic soaks to help sterilize the subcuticular space 7

Important Clinical Considerations

• Secondary infection occurs in up to 25% of cases, involving both gram-positive and gram-negative organisms 1, 3, 8
• Avoid topical steroids if purulent drainage is present until infection is adequately treated 4, 5

Special Populations

• For drug-induced paronychia, the same topical approach applies, but recognize this is primarily an inflammatory process from altered keratinocyte differentiation rather than primary infection 1, 3, 9

Key Pitfalls to Avoid

• Reassess after 2 weeks; if no improvement, escalate therapy or consider surgical intervention 1, 2

Oral Antibiotics for Paronychia

Introduction to Oral Antibiotic Use

• The American College of Oncology recommends reserving oral antibiotics for grade 2 or higher paronychia cases with suspected bacterial infection after obtaining cultures, or when topical therapy fails after 2 weeks 10

Clinical Scenarios for Oral Antibiotic Use

• Oral antibiotics should be used for grade 2 paronychia with suspected infection, characterized by nail fold edema/erythema with pain, discharge, or nail plate separation 10
• The American College of Oncology suggests using oral antibiotics for grade 3 or intolerable grade 2 cases requiring systemic therapy 10

Treatment Approach

• The American College of Oncology recommends obtaining bacterial/viral/fungal cultures before initiating oral antibiotics in grade 2 or higher cases 10
• For grade 1 paronychia, no oral antibiotics are needed, and topical povidone iodine 2% with topical antibiotics/corticosteroids should be used instead 10
• For grade 2 paronychia, cultures should be obtained if infection is suspected, and oral antibiotics should only be added if infection is confirmed 10
• For grade 3 paronychia, oral antibiotics and/or surgical drainage should be considered, and partial nail avulsion may be necessary 10

Management of Grade 1 Acute Paronychia Without Abscess

Initial Assessment and Classification

• Grade 1 paronychia is defined as nail‑fold edema or erythema without purulent drainage or fluctuance, guiding a non‑surgical, topical‑only approach. 11

First‑Line Topical Therapy

• Apply a mid‑to‑high potency topical corticosteroid ointment to the affected nail folds twice daily to reduce inflammation. [11][12]
• Use a topical antibiotic ointment concurrently with the corticosteroid to address potential superficial bacterial colonisation. 11
• Perform daily dilute vinegar soaks (1 part vinegar : 1 part water) for 10–15 minutes, twice daily, to aid antiseptic cleansing. 12

Indications for Escalation to Oral Antibiotics

• Oral antibiotics are reserved for grade 2 or higher paronychia, or when topical therapy fails after a 2‑week trial; they are not indicated for grade 1 disease lacking purulent drainage. 11
• Secondary bacterial infection occurs in approximately 25 % of all paronychia cases, with most grade 1 presentations representing primarily inflammatory processes. 11

Role of Doxycycline

• Doxycycline 100 mg twice daily is indicated for moderate‑to‑severe drug‑induced paronychia (e.g., secondary to chemotherapy or targeted cancer therapies) because of its anti‑inflammatory properties beyond antimicrobial activity. 12
• It may also be considered for recurrent, severe, or treatment‑refractory cases of drug‑induced paronychia. 12

Critical Follow‑Up

• Reassess the lesion after 2 weeks; if no improvement is observed, escalate to systemic antibiotics or consider surgical intervention, obtaining bacterial/viral/fungal cultures before initiating systemic therapy. 11

Common Pitfalls to Avoid

• Discontinue topical corticosteroids immediately if purulent drainage develops, and treat the infection first. 12

Preventive Counseling

• Advise avoidance of trauma to the peri‑ungual area by wearing comfortable footwear. 11
• Recommend keeping the affected area dry and avoiding excessive moisture. 11
• Counsel patients not to cut nails too short to reduce mechanical irritation. 11
• Suggest regular application of emollients to the cuticles and peri‑ungual skin to maintain barrier integrity. 11